Affymax, Inc. (NASDAQ:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

0
Player Avatar pchop123 (76.49) Submitted: 7/9/2012 12:41:00 PM : Underperform Start Price: $12.22 AFFY Score: -34.42

Way too PRICY for its inherent value and for me at this point

Featured Broker Partners


Advertisement